Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6801–6850 of 34725
and Mr. Jeremy Thigpen as an independent Class II director of the Company with a term expiring at the Company’s 2027 Annual Meeting of Stockholders
the Board elected Mr. Corbin J. Robertson, III as an independent Class I director of the Company with a term expiring at the Company’s 2026 Annual Meeting of Stockholders
On September 19, 2024, Seth Schorr informed Skillz Inc. (the “Company”) of his decision to resign from the Company’s Board of Directors (the “Board”), effective immediately.
increased the number of directors on the Board from nine to 10 and appointed Sonia Syngal as a director to fill the vacancy.
Paul Carl “Chip” Schorr IV notified the Board of his decision to resign from the Board and as a member of the Board’s Strategy Committee, effective September 20, 2024.
On September 23, 2024, Brian M. Larkin tendered his resignation as a director of Dynatronics Corporation (the "Company") to the Company's Board of Directors (the "Board").
On September 20, 2024 the Board of Directors (the “Board”) of Mountain & Co. I Acquisition Corp. (the “Company”) appointed Gracianne Caruso-Klein and Robert-Eduard Koenig to the Board of Directors, effective immediately
On September 20, 2024 the Board of Directors (the “Board”) of Mountain & Co. I Acquisition Corp. (the “Company”) appointed Gracianne Caruso-Klein and Robert-Eduard Koenig to the Board of Directors, effective immediately
On September 24, 2024, the Board appointed Björn Jacot to the Board of Directors to fill a vacancy on the Board.
the Board of Directors (the “Board”) of Evergy, Inc. (“Evergy”) elected Dean Newton, 54, to serve on the Board effective October 15, 2024, and Jon Rolph, 45, to serve on the Board effective January 1, 2025
the Board of Directors (the “Board”) of Evergy, Inc. (“Evergy”) elected Dean Newton, 54, to serve on the Board effective October 15, 2024, and Jon Rolph, 45, to serve on the Board effective January 1, 2025
On September 19, 2024, the Board of Directors (the “Board”) of Heidrick & Struggles International, Inc. (the “Company”), following the recommendation of its Nominating and Board Governance Committee, appointed each of Ms. Vijayabharathi V. Kaza and Mr. Timothy L. Carter to the Board, effective immediately.
On September 19, 2024, Lyle Logan notified the Board that he would resign as a member of the Board, effective upon the adjournment of the Board meeting on September 26, 2024.
On September 19, 2024, the Board of Directors (the “Board”) of Heidrick & Struggles International, Inc. (the “Company”), following the recommendation of its Nominating and Board Governance Committee, appointed each of Ms. Vijayabharathi V. Kaza and Mr. Timothy L. Carter to the Board, effective immediately.
On September 20, 2024, the Board of Directors (the “Board”) of BlackLine, Inc. (the “Company”) appointed David Henshall to serve as a member of the Board, with a term beginning on September 23, 2024.
Effective at 12 noon on September 23, 2024, Mr. Dym resigned as a member of the Board, including as Chair of the Audit Committee.
On September 23, 2024, pursuant to the Nomination Agreement, the Board appointed Marc Shiffman, age 57, as a Class II director of the Board.
On September 21, 2024, the Board of Directors (the “Board”) of eHealth, Inc. (the “Company”) appointed Prama Bhatt as a member of the Board, effective as of September 24, 2024.
On September 18, 2024, M2i Global, Inc. (“the Company”) appointed Michael Sander, a strategic and investment professional of more than 30 years with invaluable experience in technology, finance, and real estate to its Board of Directors, as an independent director.
appointed Rear Adm. H. Wyman Howard III, Ret. as a director of the Board, effective as of October 1, 2024
On September 21, 2024, the Board of Directors (the Board) of Hormel Foods Corporation (the Company) elected Debbra Schoneman to the Board, effective immediately on September 21, 2024.
On September 20, 2024, the Board of Directors (the “Board”) of Mural Oncology plc (the “Company”), upon recommendation from the Nominating and Corporate Governance Committee of the Board, appointed Sachiyo Minegishi as a director in accordance with the Company’s articles of association to serve on the Board with an initial term expiring at the Company’s 2025 annual general meeting.
Jeffrey L. Edwards notified Lifecore Biomedical, Inc. (the “Company”) that he has elected not to stand for re-election to serve as a director of the Board of Directors of the Company (the “Board”) at the Company’s 2024 annual meeting of stockholders (the “Annual Meeting”)
Ray Diradoorian notified the Company that he intends to resign as a director of the Board effective as of immediately prior to the Annual Meeting.
On September 20, 2024, the Board elected Lynda Grindstaff and Roberto García to the Board of Directors effective immediately.
On September 20, 2024, the Board elected Lynda Grindstaff and Roberto García to the Board of Directors effective immediately.
Effective September 23, 2024, the Board of Directors (the “Board”) of SilverBox Corp IV (the “Company”) appointed Reed Seaton to the Board as a director of the Company.
Teresa Barger Independent Director, Member of Audit Committee and Compensation Committee
Andrew Bartley Independent Director, Chair of Audit Committee and Member of Compensation Committee
Pursuant to the terms of his employment agreement, Dr. Varma’s service on the Company’s Board of Directors also automatically ended effective immediately.
On September 18, 2024, Richard Noll, a director of the Company, notified the Company of his decision to resign as a director of the Company, effective immediately.
the Board elected Ann C. Gallo to serve as a director of the Company
• Rodney E. Hood, former Chair of the Board, National Credit Union Administration (NCUA), was elected to fill an independent directorship.
On September 19, 2024 its board of directors (the “Board”) appointed Claude E. Wade to the Company’s Board effective March 1, 2025.
The Company also announced that Wendy Watson will retire from the Board after her current term expires at the annual meeting of shareholders in April 2025.
As a result, Mr. Greenlaw ceased to serve as a member of the Old Dominion Electric Cooperative board of directors on such date.
On September 17, 2024, Daniel N. Swisher Jr., a member of the Board of Directors (the “Board”) of Protagonist Therapeutics, Inc. (the “Company”) and a member of the Audit Committee of the Board, resigned from the Board, effective September 17, 2024.
On September 19, 2024, Dr. Jay K. Varma began an indefinite leave of absence from his positions as Executive Vice President and Chief Medical Officer of SIGA Technologies, Inc. (the “Company”) and as a member of the Board of Directors of the Company.
On September 19, 2024, the Board elected Alexi Wellman to the Board of Directors (the “Board”) of EverCommerce Inc. (the “Company”) as a Class II director, effective September 23, 2024.
On September 19, 2024, Debby Soo resigned from the Board, effective October 31, 2024.
On September 16, 2024, Marie Myers, a member of the Board of Directors (the “Board”) of KLA Corporation (the “Company”), notified the Company that she will not stand for reelection to the Board at the Company’s 2024 annual meeting of stockholders (the “Annual Meeting”), and therefore her term as a director will end at the Annual Meeting.
On September 17, 2024, the Board of Directors (the “Board) of Forte Biosciences, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Richard Vincent and Shiv Kapoor to the Board to fill the vacancies on the Board created by the resignations of each of Donald A. Williams and Lawrence Eichenfield, each of whom had tendered their resignation from the Board as detailed below, in each case effective September 17, 2024.
On September 17, 2024, the Board of Directors (the “Board) of Forte Biosciences, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Richard Vincent and Shiv Kapoor to the Board to fill the vacancies on the Board created by the resignations of each of Donald A. Williams and Lawrence Eichenfield, each of whom had tendered their resignation from the Board as detailed below, in each case effective September 17, 2024.
On September 17, 2024, the Board of Directors (the “Board) of Forte Biosciences, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Richard Vincent and Shiv Kapoor to the Board to fill the vacancies on the Board created by the resignations of each of Donald A. Williams and Lawrence Eichenfield, each of whom had tendered their resignation from the Board as detailed below, in each case effective September 17, 2024.
On September 17, 2024, the Board of Directors (the “Board) of Forte Biosciences, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Richard Vincent and Shiv Kapoor to the Board to fill the vacancies on the Board created by the resignations of each of Donald A. Williams and Lawrence Eichenfield, each of whom had tendered their resignation from the Board as detailed below, in each case effective September 17, 2024.
On September 16, 2024, Mark Richardson resigned as a director of SunHydrogen, Inc.
the Board appointed Mr. Peter Bordes, to serve as a director of the Company, effective immediately, to fill Ms. Watt’s vacancy on the Board.
On September 18, 2024, Collective Audience, Inc. (the “Company”) effectuated the resignation of Ms. Nadine Watt, a member of the Board of Directors (the “Board”) pursuant to the provisions of that certain Voting Agreement, dated as of November 2, 2023, by and between the Company, Abri Ventures I, LLC (the “Sponsor”) and other parties thereto.
appointed Kamran Cheema to the Board to serve for a term expiring at the Company’s 2024 annual meeting of stockholders and until his successor is duly elected and qualified or until his earlier death, resignation or removal.
Mr. Piggott and Thomas Humble both resigned from their positions as members of the Board.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.